Evidence map›Paper›PMID 35586578›Full record

ArticlePatient preference and adherence2022

The Health-Related Quality of Life of Patients with Type 2 Diabetes in Saudi Arabia.

Amal Khaleel AbuAlhommos, Amjad Heji Alturaifi, Amnah Mohammed Al-Bin Hamdhah, Hawra Hassan Al-Ramadhan, Zahra Abdullah Al Ali, Hawra Jumah Al Nasser

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Patient preference and adherence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Amal Khaleel AbuAlhommosPharmacy Practice Department, Clinical Pharmacy College, King Faisal University, Alhasa, Saudi Arabia.ORCID 0000-0003-4366-9284
Amjad Heji AlturaifiPharmacy Practice Department, Clinical Pharmacy College, King Faisal University, Alhasa, Saudi Arabia.
Amnah Mohammed Al-Bin HamdhahPharmacy Practice Department, Clinical Pharmacy College, King Faisal University, Alhasa, Saudi Arabia.
Hawra Hassan Al-RamadhanPharmacy Practice Department, Clinical Pharmacy College, King Faisal University, Alhasa, Saudi Arabia.
Zahra Abdullah Al AliPharmacy Practice Department, Clinical Pharmacy College, King Faisal University, Alhasa, Saudi Arabia.
Hawra Jumah Al NasserPharmacy Practice Department, Clinical Pharmacy College, King Faisal University, Alhasa, Saudi Arabia.
King Faisal University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Diabetes mellitus (DM) is one of the most common chronic diseases in the world. Diabetes mellitus has a major effect on patients' quality of life, especially when the patient has other comorbidities. Therefore, this study aims to assess the quality of life of type 2 diabetic patients in the Al-Ahsa region of Saudi Arabia. Methods: This was a cross-sectional study, which was conducted from September 2020 to May 2021 on patients with type 2 diabetes mellitus in the Al-Ahsa region of Saudi Arabia. Inclusion criteria were patients diagnosed with T2DM and aged 18 years and older. The EQ-5D-5L tool was used in this study to measure the quality of life. Results: A total of 321 patients with T2DM participated in the study. Only 8.4% of the study participants reported that their disease did not let them do their daily activities at all. The most commonly reported problems related to diabetes mellitus and its effect on patients' quality of life were pain/discomfort (around 68.0% of the patients reported some sort of problems in this dimension), followed by mobility, and depression and anxiety. There was a significant difference between males and females in terms of their quality of life, specifically self-care, pain and discomfort, and depression and anxiety (p<0.05). Patients from different marital statuses, education levels, employment status, and duration of the disease showed a significant difference in quality of life, except for depression and anxiety (p>0.05). Conclusion: Pain/discomfort, mobility, and depression/anxiety are the main problems that are affecting diabetic patients' quality of life. Future studies are recommended to explore the effectiveness of patient tailored interventions to decrease the negative impact of these dimensions on patients' quality of life.

Indexed as

patientsquality of lifeSaudi Arabiatype 2 diabetes mellitus

Identifiers

PMID35586578
PMCPMC9109984
OpenAlexW4280498884

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.